PebbleAtlas
PEBBLE / ATLAS
Open research access
PRECLINICAL PUBLICATION · 1987

A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage.

Mixed / TBI

Evidence by therapy association

Study details and outcomes are extracted in the context of a specific intervention. Separate associations are retained rather than silently merged.

PMID 3039107 ↗1987Reported benefit

A nonglucocorticoid steroid analog of methylprednisolone duplicates its high-dose pharmacology in models of central nervous system trauma and neuronal membrane damage.

MixedTBIClosed-head / concussionMaleU-72099E up to 100 mg/kg/day; methylprednisolone 30 mg/kg/d…

Model: Concussive head injury in mice, plus in vitro lipid peroxidation-induced membrane damage in rat brain synaptosomes

U-72099E showed no glucocorticoid activity, with no suppression of body weight gain or thymic involution at up to 100 mg/kg/day and no suppression of adrenocorticotropin secretion at 10^-5 M or lower, whereas methylprednisolone 30 mg/kg/day completely inhibited body weight gain and reduced thymus w…

Extraction: extract · Subtype source: rule · Supplied extraction confidence: 0.6. Machine-extracted fields require source verification.